Dear Dr. Renukaprasad A R,  Lung cancer has now become the most common cause of cancer-related death in men and the second most common cause of death in women, with the number of deaths from lung cancer estimated at 135,000 patients per year. More people are dying from lung cancer than from prostate, breast, brain, and colorectal cancers combined. Join us for an exclusive webinar on 2nd March 2023 at 4:30 PM and 9:30 PM IST with our renowned International experts in oncology, who will discuss clinical evidence for ramucirumab as a second-line treatment option for metastatic non-small cell lung cancer (mNSCLC) patients following immune checkpoint inhibitor and chemotherapy. The experts will answer your questions live. We look forward to your participation in this informative discussion! | .png)
No comments:
Post a Comment